Tg Therapeutics, Inc.
TGTX
Revenue
73.47M
▲9.99M▲15.74%
3 Months ChangeAssets
401.21M
▲27.88M▲7.47%
3 Months ChangeLiabilities
223.64M
▲10.43M▲4.89%
3 Months ChangeFree Cash Flow
-68.70M
▲12.73M▲15.63%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-09
Form 10-Q
ID: 0001437749-24-025853
2024-08-06
Form 8-K
ID: 0001437749-24-024718
2024-06-17
Form 8-K
ID: 0001437749-24-020510
2024-05-06
Form 10-Q
ID: 0001437749-24-014849
2024-05-01
Form 8-K
ID: 0001437749-24-014062
2024-02-28
Form 8-K
ID: 0001437749-24-005802
2024-01-10
Form 8-K
ID: 0001437749-24-001061
2023-11-06
Form 10-Q
ID: 0001437749-23-030412
2023-11-01
Form 8-K
ID: 0001437749-23-029660
2023-08-04
Form 10-Q
ID: 0001558370-23-013429